Nature Biotechnology ranked George Georgiou, a professor in the Cockrell School of Engineering, one of the world’s top 20 translational researchers in 2013.

Georgiou, a renowned biomedical engineer and molecular biologist, is a leading authority in the discovery, development and manufacturing of protein therapeutics. Nature Biotechnology recognized Georgiou for his output of U.S. and European patents issued and papers of translational interest published.

Over his 28-year career, Georgiou has been one of the most active researchers at The University of Texas at Austin. He is co-inventor of a total of 29 U.S. patents and 46 U.S. patent applications (38 published and eight pending). According to Georgiou, 14 patent suites, each comprising multiple patents​, have been licensed to 17 biotechnology or pharmaceutical companies.

At UT Austin, Georgiou’s laboratory has developed methods for the discovery, manufacturing and use of therapeutic proteins, and also discovered several protein drugs currently in clinical development.